Tavneos Capsule
Product Images NDC 73556-168

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tavneos (NDC 73556-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chemocentryx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Avacopan 01)

Chemical structure of avacopan, the active ingredient in TAVNEOS (10 mg) capsules. The structure shows the molecular arrangement and bonds characteristic of avacopan's chemical composition.*

FDA Label Image

Figure 1 (Avacopan 02)

A forest plot chart titled 'Sustained remission at Week 52' comparing response differences between TAVNEOS and Prednisone across various patient strata. It shows overall response, background therapy, ANCA positivity, AAV status, and AAV type with mean percentages for TAVNEOS and Prednisone, where positive values favor TAVNEOS and negative values favor Prednisone.*

FDA Label Image

10 mg 180-count Bottle Label (Avacopan 03)

TAVNEOS 10 mg oral capsules label by ChemoCentryx, Inc. The label states each capsule contains 10 mg of avacopan and includes storage instructions, pharmacist dispensing information, and safety warnings. The container holds 180 capsules, and the label displays the NDC 73556-168-01.*

FDA Label Image

10 mg 180-count Bottle Carton Label (Avacopan 04)

Packaging label for TAVNEOS (avacopan) capsules, 10 mg, oral use. The label shows the NDC 73556-168-01 and states a package quantity of 180 capsules. It is manufactured for ChemoCentryx, Inc. by Thermo Fisher Scientific in Cincinnati, OH, USA. The label includes storage instructions, a pharmacist advisory to dispense with a medication guide, and warnings about seal integrity and child safety.*

FDA Label Image

10 mg 30-count Bottle Label (Avacopan 05)

TAVNEOS (avacopan) 10 mg oral capsules packaging label displaying product name, active ingredient, and strength. The label indicates a package size of 30 capsules, Rx only. It includes statements about storage conditions, usage instructions for pharmacists, manufacturer details (ChemoCentryx, Inc. by Thermo Fisher Scientific, Cincinnati, USA), and safety warnings such as not using if the seal is broken and keeping out of children's reach.*

FDA Label Image

10 mg 30-count Bottle Carton Label (Avacopan 06)

Packaging label for TAVNEOS 10 mg capsules, containing avacopan, by ChemoCentryx, Inc. The label shows the proprietary name TAVNEOS with the generic name avacopan below, dosage strength of 10 mg, and indicates 30 capsules per package. It includes storage instructions, a barcode, manufacturer details, and warnings such as not to use if the seal is broken and to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.